scAnyOmics: Foundation-Model Distillation for Any-to-Any Completion of Multi-omics Virtual Cells
Organizations: Department of Technology Management for Innovation, Graduate School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan · State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, 361102, China · Department of Computing, Hong Kong Polytechnic University, Hong Kong S.A.R., China
Abstract
Recent advances in single-cell technologies have enabled the profiling of multiple molecular modalities, including transcriptomics, proteomics, and chromatin accessibility, providing a more comprehensive understanding of cellular states. However, integrating heterogeneous modalities and predicting missing molecular information remain challenging, particularly when paired measurements are limited. Here, we introduce scAnyOmics, a generative framework that distills knowledge from a frozen single-cell foundation model into a multimodal student model. scAnyOmics integrates scRNA-seq, protein-marker measurements, and scATAC-seq into a shared representation, enabling cross-modal prediction and reconstruction of missing modalities. We assembled 690,880 cells from six publicly available studies, covering both paired and partially paired multi-omics measurements, to systematically evaluate its predictive performance. We further evaluated scAnyOmics on held-out donor data, where it outperformed baseline methods across multiple evaluation metrics. Beyond cross-modal reconstruction, we explored its applications in cell-type annotation, perturbation-response prediction, and biological age estimation. Overall, scAnyOmics provides a unified framework for integrating incomplete single-cell multi-omics data and transferring pretrained biological knowledge, supporting the development of virtual cell models across diverse cellular contexts and experimental platforms.
Figures & tables
| GEO series (PMID) | Biological material | Condition | Assay(s) | Blocks / GSMs | Donors | Anti- bodies |
|---|---|---|---|---|---|---|
| GSE158013 (33835024) | Leukapheresis PBMCs, dead-cell/neutrophil-depleted | Unstimulated | TEA-seq (5 libraries); 10x Multiome, nuclei or permeabilized cells (2 libraries) | 7 / 7 | 1 (HMN200910) | 45 |
| GSE200417 (35739535) | Peripheral blood pan-T cells, healthy donors aged 18–35 years | 12 h CD3/CD28/CD2 + IL-1 + IL-23 PGE2/TGF- | DOGMA-seq, DIG (2 libraries) and LLL (1 library) permeabilization; CITE-seq (1 library) | 7 / 4 | Not resolved | 154 |
| GSE214546 (37845489) | PBMCs | Unstimulated | TEA-seq | 19 / 19 | 16 donors + 1 control individual | 54 |
| GSE236422 (—) | Blood T cells from healthy donors | Bortezomib, lenalidomide, dexamethasone or DMSO 4/24/72 h; untreated 0 h | TEA-seq | 12 / 12 | Not resolved | 54 |
| GSE156478 (34083792) | PBMCs | Control arm (16 h IL-2) | CITE-seq | 1 / 1 | Not resolved | 113 |
| GSE166188 (34083792) | PBMCs | Control arm (16 h IL-2) | DOGMA-seq, LLL permeabilization | 1 / 1 | Not resolved | 107 |
| GEO | Total cells | RNA+ADT+ATAC | RNA+ADT | RNA+ATAC | RNA | Split (train / test) |
| GSE158013 | 59,151 | 37,745 | 4,682 | 14,680 | 2,044 | 49,911 / 9,240 |
| GSE200417 | 68,138 | 41,903 | 14,821 | 11,414 | 0 | 56,195 / 11,943 |
| GSE214546 | 367,955 | 53,423 | 314,532 | 0 | 0 | 246,439 / 121,516 |
| GSE236422 | 181,518 | 168,062 | 13,456 | 0 | 0 | 172,516 / 9,002 |
| GSE156478 | 5,527 | 0 | 5,527 | 0 | 0 | 5,527 / 0 |
| GSE166188 | 8,591 | 8,591 | 0 | 0 | 0 | 8,591 / 0 |